Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Pozycja w akcjach #17340
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Cena akcji
$2.12
Kapitalizacja rynkowa
$244.50M
Zmiana (1 dzień)
-3.99%
Zmiana (1 rok)
93.78%
Kraj
CA
Handel Cardiol Therapeutics Inc. (CRDL)

Kategoria

Historia ceny akcji dla Cardiol Therapeutics Inc. (CRDL)
Najwyższa cena zamknięcia: $2.18 dnia 2026-09-01

Najniższa cena zamknięcia: $3.27 dnia 2018-12-01
Historia cen akcji firmy Cardiol Therapeutics Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 17.57%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$163.16 27.67%
DE
$38.45 26.55%
JP
$21.20 18.26%
IN
$209.91 21.50%
CH